[go: up one dir, main page]

AU2002364804A1 - Use of l isomers of amino acid derivatives of hydroxyguanidine for producing no, pharmaceutical compositions containing same and pharmaceutical uses - Google Patents

Use of l isomers of amino acid derivatives of hydroxyguanidine for producing no, pharmaceutical compositions containing same and pharmaceutical uses

Info

Publication number
AU2002364804A1
AU2002364804A1 AU2002364804A AU2002364804A AU2002364804A1 AU 2002364804 A1 AU2002364804 A1 AU 2002364804A1 AU 2002364804 A AU2002364804 A AU 2002364804A AU 2002364804 A AU2002364804 A AU 2002364804A AU 2002364804 A1 AU2002364804 A1 AU 2002364804A1
Authority
AU
Australia
Prior art keywords
hydroxyguanidine
isomers
producing
amino acid
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002364804A
Other versions
AU2002364804A8 (en
Inventor
Petra Beranova
Jean-Luc Boucher
Sylvie Dijols
Andrei Klechtchev
Daniel Mansuy
Bernard Muller
Christa Schott
Jean-Claude Stoclet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite Paris Descartes
Universite de Strasbourg
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite Paris Descartes
Universite de Strasbourg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite Paris Descartes, Universite de Strasbourg filed Critical Centre National de la Recherche Scientifique CNRS
Publication of AU2002364804A1 publication Critical patent/AU2002364804A1/en
Publication of AU2002364804A8 publication Critical patent/AU2002364804A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002364804A 2001-11-29 2002-11-29 Use of l isomers of amino acid derivatives of hydroxyguanidine for producing no, pharmaceutical compositions containing same and pharmaceutical uses Abandoned AU2002364804A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0115457 2001-11-29
FR0115457A FR2832634A1 (en) 2001-11-29 2001-11-29 USE OF L ISOMERS OF AMINOACID DERIVATIVES OF HYDROXYGUANIDINE FOR THE PRODUCTION OF NO, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PHARMACEUTICAL USES
PCT/FR2002/004117 WO2003045369A2 (en) 2001-11-29 2002-11-29 Use of l isomers of amino acid derivatives of hydroxyguanidine for producing no, pharmaceutical compositions containing same and pharmaceutical uses

Publications (2)

Publication Number Publication Date
AU2002364804A1 true AU2002364804A1 (en) 2003-06-10
AU2002364804A8 AU2002364804A8 (en) 2003-06-10

Family

ID=8869931

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002364804A Abandoned AU2002364804A1 (en) 2001-11-29 2002-11-29 Use of l isomers of amino acid derivatives of hydroxyguanidine for producing no, pharmaceutical compositions containing same and pharmaceutical uses

Country Status (3)

Country Link
AU (1) AU2002364804A1 (en)
FR (1) FR2832634A1 (en)
WO (1) WO2003045369A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9387185B2 (en) 2009-01-09 2016-07-12 Christian-Albrechts-Universität Zu Kiel N-ω-hydroxy-L-arginine derivatives for the treatment of diseases
US20110160200A1 (en) * 2009-11-23 2011-06-30 Cardioxyl Pharmaceuticals, Inc. Nitroxyl Progenitors for the Treatment of Pulmonary Hypertension
AU2010328230B2 (en) 2009-12-07 2016-06-02 Cardioxyl Pharmaceuticals, Inc. Bis-acylated hydroxylamine derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU756136B2 (en) * 1997-06-23 2003-01-02 Queen's University At Kingston Microdose therapy
US6436997B1 (en) * 1998-06-01 2002-08-20 Nitromed, Inc. Endogenous nitric oxide synthesis under conditions of low oxygen tension
DE60042611D1 (en) * 1999-10-29 2009-09-03 Nitromed Inc METHOD OF TREATING VASCULAR DISEASES, DIGITAL AWARDS
WO2001078717A1 (en) * 2000-04-12 2001-10-25 Cornell Research Foundation, Inc. Pharmacotherapy for vascular dysfunction associated with deficient nitric oxide bioactivity
WO2001089519A1 (en) * 2000-05-22 2001-11-29 Nitromed, Inc. Thromboxane inhibitors, compositions and methods of use related applications
AU5939901A (en) * 2000-10-27 2002-05-06 Nitromed Inc Methods of treating vascular diseases characterized by nitric oxide insufficiency

Also Published As

Publication number Publication date
WO2003045369A3 (en) 2004-06-03
AU2002364804A8 (en) 2003-06-10
WO2003045369A9 (en) 2004-07-01
FR2832634A1 (en) 2003-05-30
WO2003045369A2 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
AU2002363236A1 (en) Compounds, pharmaceutical compositions and methods of use therefor
HUP0303128A3 (en) Novel succinate salt of o-desmethyl-venlafaxine, process for preparation thereof, its use and pharmaceutical composition containing it
HUP0401083A3 (en) 4-amino-6-phenyl-pyrrolo [2,3-d] pyrimidine derivatives, pharmaceutical compositions containing them and process for the preparation of the compounds
HUP0302656A3 (en) Fumaric acid amides, their use for preparation of pharmaceutical compositions and pharmaceutical compositions containing the compounds
HUP0201646A3 (en) Novel alpha-amino acid derivatives, process for producing them and pharmaceutical compositions containing them
AU2002352420A1 (en) Pyrazine compounds and pharmaceutical compositions containing them
AU2002255077A1 (en) Derivatives of N-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
IL190218A0 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
AU2001260455A1 (en) Cyclic amino acid derivatives useful as pharmaceutical agents
PL367447A1 (en) Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
AU4710499A (en) Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use ofsuch compounds
AU4949800A (en) 2-arylpurine-9-acetamide derivatives, process for the preparation thereof, medicinal compositions containing the same and intermediates of the derivatives
HUP0401747A3 (en) Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
AU2001270778A1 (en) Production, stabilisation and use of reduced forms of pharmaceutical compounds
AU2002358676A1 (en) Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2001267886A1 (en) Epoxycarboxylic acid amides, azides and amino alcohols and processes for preparation of alpha-keto amides by using them
ZA200500203B (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
HUP0401654A3 (en) Heterokondensated pyrimidine derivatives, their intermediates, preparations of the compounds and pharmaceutical compositions containing them
HUP0300231A3 (en) Process for the preparation of high purity perindopril and intermediates useful in the synthesis, pharmaceutical compositions containing the compound and their use
WO2004056832A3 (en) Epothilone derivatives
HUP0401773A3 (en) Use of [(2-amino-3,4-dioxo-1cyclobuten-1-yl)amino]alkanacid derivatives for the preparation pharmaceutical compositions usable for treatment of pain
AU2002306687A1 (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
AU2002364804A1 (en) Use of l isomers of amino acid derivatives of hydroxyguanidine for producing no, pharmaceutical compositions containing same and pharmaceutical uses
AU2003274676A1 (en) Antimicrobial oxazolidinones, process of their preparation, and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase